Literature DB >> 1571823

Management of corticosteroid-induced osteoporosis: a clinician's perspective.

S L Silverman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1571823     DOI： 10.1007/bf00298781

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  25 in total

1.  Corticosteroid effects on proximal femur bone loss.

Authors:  P Sambrook; J Birmingham; S Kempler; P Kelly; S Eberl; N Pocock; M Yeates; J Eisman
Journal:  J Bone Miner Res       Date:  1990-12       Impact factor: 6.741

2.  Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cells in vitro.

Authors:  W A Peck; J Brandt; I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

3.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.

Authors:  B L Riggs; S F Hodgson; W M O'Fallon; E Y Chao; H W Wahner; J M Muhs; S L Cedel; L J Melton
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

4.  Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.

Authors:  S Balsan; D Stéru; A Bourdeau; R Grimberg; G Lenoir
Journal:  Calcif Tissue Int       Date:  1987-06       Impact factor: 4.333

5.  Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration.

Authors:  T J Hahn; L R Halstead; S L Teitelbaum; B H Hahn
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

6.  Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy.

Authors:  O S Gluck; W A Murphy; T J Hahn; B Hahn
Journal:  Arthritis Rheum       Date:  1981-07

7.  Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.

Authors:  O D Messina; J C Barreira; J R Zanchetta; J A Maldonado-Cocco; C E Bogado; O N Sebastián; D Flores; A M Riopedre; G Redondo; A Lázaro
Journal:  J Rheumatol       Date:  1992-10       Impact factor: 4.666

8.  Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases.

Authors:  T R Dykman; K M Haralson; O S Gluck; W A Murphy; S L Teitelbaum; T J Hahn; B H Hahn
Journal:  Arthritis Rheum       Date:  1984-12

9.  Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

Authors:  I R Reid; A R King; C J Alexander; H K Ibbertson
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321

10.  Calcium supplements in the prevention of steroid-induced osteoporosis.

Authors:  I R Reid; H K Ibbertson
Journal:  Am J Clin Nutr       Date:  1986-08       Impact factor: 7.045
View more
  5 in total

Review 1.  Oral antiresorptive therapy.

Authors:  Ira Pande; David J Hosking
Journal:  Curr Rheumatol Rep       Date:  2005-03       Impact factor: 4.592

Review 2.  Oral antiresorptive therapy.

Authors:  Ira Pande; David J Hosking
Journal:  Curr Osteoporos Rep       Date:  2004-12       Impact factor: 5.096

Review 3.  Perspectives on osteoporosis in pediatric inflammatory bowel disease.

Authors:  Manisha Harpavat; David J Keljo
Journal:  Curr Gastroenterol Rep       Date:  2003-06

4.  Genetic polymorphism of geranylgeranyl diphosphate synthase (GGSP1) predicts bone density response to bisphosphonate therapy in Korean women.

Authors:  Hyung Jin Choi; Ji Yeob Choi; Sun Wook Cho; Daehee Kang; Ki Ok Han; Sang Wan Kim; Seong Yeon Kim; Yoon-Sok Chung; Chan Soo Shin
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

5.  Changes in calcium and bone metabolism during treatment with low dose prednisone in young, healthy, male volunteers.

Authors:  W F Lems; J W Jacobs; H J Van Rijn; J W Bijlsma
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.